Prof Martin Reck did his medical training at the University of Hamburg, Germany, from 1986 to 1993. He completed his doctorate at the General Hospital Wandsbek, Hamburg, in 1995 and received post-graduate training at the Hospital Grosshansdorf, Grosshansdorf, Germany. In 2001 he was appointed as a specialist in internal medicine and in 2002 he was also appointed as a specialist in pulmonology. In 2008 he was awarded a post-doctoral lecturing qualification by the University of Schleswig-Holstein, Germany.
Prof Reck has been a Principal Investigator (PI) or Co-PI in various clinical trials since 1993. His main interests are targeted therapies in non-small-cell lung cancer, new approaches in small-cell lung cancer and modern therapies in malignant pleural mesothelioma, as well as translational research related to predictive markers. He has been involved in several key trials investigating new treatment approaches in treatment of advanced stage of disease like Maintenance treatment or treatment with targeted therapies as well as key biomarker trials.
Prof. Reck is Head of the Department of Thoracic Oncology as well as Head of the Clinical Trial Department in the Department of Thoracic Oncology at the Lung Clinic Grosshansdorf. Furthermore he is PI in the German centre for lung research (DZL) in the area of lung cancer.
Prof Reck is member of the German Working Group for Lung Cancer, the German Cancer Society, the German Society of Pulmonology, the International Association for the Study of Lung Cancer, the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO).